SUBSCRIBE: Print / eNewsletter
Reflections on Caring for Patients With Cancer at the End of Life
Most metastatic cancer patients are still receiving aggressive methods of treatment near the end of life, and palliative/supportive measures are significantly underutilized.
Induction Chemo in Head and Neck Cancer: Is the Jury Still Out?
To date, there is still no strong evidence that induction chemotherapy improves outcomes for locally advanced head and neck cancer.
ASCO Poster Sessions: Breast Cancer in Elderly Women
As physicians, we strive to do no harm, and there is a narrow therapeutic window when treating elderly patients with cancer.
Top 5 Reasons to Participate in Advocacy in Washington, DC
Advocacy is about making sure that our lawmakers enact the best healthcare policies for our patients. Just as we have a duty to our patients in the clinic, we also have a duty to advocate for laws that benefit patients’ health.
Oral Cancer Patient Presents With Pain in Mouth
A 58-year-old man treated with chemoradiotherapy for squamous cell carcinoma of the tonsil presents at follow-up with pain in the back of his mouth. What is the most likely diagnosis?
Management of a 53-Year-Old Anal Cancer Patient
A 53-year-old man treated for squamous cell carcinoma of the anus presents 4 weeks post-treatment with a 2-cm anal mass. What is the most appropriate next step in his management?
Hepatic Encephalopathy in Patient With History of Alcohol Abuse
Imaging on a 60-year-old man demonstrates multiple bony lesions in the spine that could indicate metastatic liver cancer. What is the best diagnostic tool to confirm the diagnosis?
Update From the ASCO 2015 Genitourinary Cancers Symposium
At this year’s ASCO GU Cancers Symposium, several high-impact and potentially practice-changing abstracts were presented during the prostate cancer session.
Vita Brevis, Ars Longa: Why I Chose to Be a Doctor
We are in the midst of a radical shift in the way modern medicine is practiced, and there are many challenges facing physicians today. So, why did I become one?
Patient Diagnosed With Clinical Stage T1c Prostate Cancer
After receiving a PSA screening exam, a 65-year-old man is diagnosed with clinical stage T1c prostate cancer. What imaging study is most appropriate to complete his workup?